Antibiotic resistance is a ‘ticking time bomb’
13 March 2013 News and Analysis
Efforts to tackle the threat will need new thinking, but their may be no easy solutions or short cuts to new drugs

Tests for the most appropriate antibiotic choice are performed for life-threatening patient infections. However, microbes have to be grown on agar plates from a very small patient sample which delays results for a few days. Hiroaki Suzuki et al have designed a microfluidic device that is able to determine the most effective antibiotic treatment in just 12 hours.
The device consists of eight separate culture chambers, which can test a range of concentrations simultaneously. Once bacteria are added the growth rate is recorded using a reflection-microscopy technique. The images obtained allow the volume of bacteria present to be calculated, which in turn allows estimation of the minimum concentration of antibiotic required to effectively treat a patient.
Shuqi Wang, an expert in microfluidic diagnostic devices, at Harvard Medical School, USA, comments ‘This method has broad potential applications to help clinicians choose the right antibiotics at the right concentration against given bacteria, and thus to avoid empirical antibiotic treatment. In particular, the multi-chamber microfluidic design allows simultaneous evaluation of multiple antibiotics at various concentrations in one testing.’
R Takagi et al, Analyst, 2013, DOI:10.1039/c2an36323b
13 March 2013 News and Analysis
Efforts to tackle the threat will need new thinking, but their may be no easy solutions or short cuts to new drugs
1 April 2012 Feature
Could light prove to be the ultimate weapon in the battle against deadly superbugs?
13 May 2013 Research
'Liquid fingerprinting' can 'taste' the difference between red wines, mineral waters and vodkas
15 May 2013 Research
The environmental legacy of salvaging gold from electronic waste can be dramatically cut using corn starch instead of cyanide
14 May 2013 News and Analysis
New legislation proposes the appointment of a public champion for research
7 May 2013 News and Analysis
While the EU is zeroing in on neonicotinoids as a major cause of bee deaths, the US is looking elsewhere